Apella Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Apella Capital's PFE Position: Q3 2026 in Review
Apella Capital increased its Pfizer (PFE) stake by 22% in Q3 2026, buying an estimated $275K and bringing the position to 56,927 shares worth $1.59M. The position accounts for 0.02% of the portfolio, ranked #310.
Apella Capital first reported a position in PFE in Q1 2020 and has held it in 26 quarters since. 2,920 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Apella Capital held 56,927 shares of Pfizer worth $1.59M as of Q3 2026.
- Apella Capital bought 10,327 Pfizer shares in Q3 2026, an estimated $275K.
- Pfizer made up 0.02% of Apella Capital's portfolio in Q3 2026, its #310 holding.
- Apella Capital first reported a position in Pfizer in Q1 2020 and has held it in 26 quarters since.
- 2,920 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Apella Capital's 13F filing for Q3 2026, filed 8 Oct 2026.